// App-Quantinova.ai

4188 : RNAi and CRISPR/Cas9 based in vivo models for drug discovery

Researchers

Presenter

  • Prem K. Premsrirut

Principal Investigators

  • Gregory Martin

  • Lukas Dow

  • Sang Yong Kim

  • Johannes Zuber

  • Scott Lowe

  • Greg Hannon

Medical Centers

  • Mirimus Inc., Woodbury, NY

  • Charles River Laboratories, Wilmington, ME

  • Weill Cornell Medical College, New York, NY

  • New York University, New York, NY

  • The Research Institute of Molecular Pathology, Vienna, Austria

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Cancer Research UK, Cambridge, United Kingdom.

Locations

  • United States

  • United Kingdom

  • Austria

Companies

  • Mirimus Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Doxycycline

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved